title: Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis.
abstract: Epigenetic association studies have demonstrated differential promoter methylation in the core circadian genes in breast cancer cases relative to cancer-free controls. The current pilot study aims to investigate whether epigenetic changes affecting breast cancer risk could be caused by circadian disruption through exposure to light at night. Archived DNA samples extracted from whole blood of 117 female subjects from a prospective cohort conducted in Denmark were included in this study. A polymerase chain reaction (PCR)-based method was used for detection of gene-promoter methylation, whereas genome-wide methylation analysis was performed using the Illumina Infinium Methylation Chip. Long-term shiftwork resulted in the same promoter hypomethylation of CLOCK and hypermethylation of CRY2, as was previously observed in breast cancer case-control studies. Genome-wide methylation analysis further discovered widespread methylation alterations in shiftworkers, including changes in many methylation- and cancer-relevant genes. Pathway analysis of the genes with altered methylation patterns revealed several cancer-related pathways. One of the top three networks generated was designated as "DNA replication, recombination, and repair, gene expression, behavior" with ESR1 (estrogen receptor α) featured most prominently in the network, underscoring the potential breast cancer relevance of the genes differentially methylated in long-term shiftworkers. These results, although exploratory, demonstrate the first evidence of the cancer-relevant epigenetic effects of night shiftwork, which warrant further investigation. Considering there are millions of shiftworkers worldwide, understanding the effects of this exposure may lead to novel strategies for cancer prevention and new policies regulating shiftwork.
authors.affiliation: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA. yong.zhu@yale.edu
authors.forename: Yong
authors.initials: Y
authors.lastname: Zhu
authors.forename: Richard G
authors.initials: RG
authors.lastname: Stevens
authors.forename: Aaron E
authors.initials: AE
authors.lastname: Hoffman
authors.forename: Anne
authors.initials: A
authors.lastname: Tjonneland
authors.forename: Ulla B
authors.initials: UB
authors.lastname: Vogel
authors.forename: Tongzhang
authors.initials: T
authors.lastname: Zheng
authors.forename: Johnni
authors.initials: J
authors.lastname: Hansen
mesh_terms: D056925:Circadian Rhythm Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D057890:Epigenomics; D005260:Female; D020869:Gene Expression Profiling; D015894:Genome, Human / Q000502:physiology*; D006801:Humans; D008745:Methylation; D008875:Middle Aged; D011401:Promoter Regions, Genetic; D013997:Time Factors; D014940:Work Schedule Tolerance / Q000502:physiology*
chemical_list: D056925:Circadian Rhythm Signaling Peptides and Proteins
references.citation: BMC Genomics. 2010 Feb 25;11:137
references.pmid: 20181289
references.citation: Nature. 2005 Oct 13;437(7061):1032-7
references.pmid: 16136080
references.citation: Cancer Prev Res (Phila). 2010 Apr;3(4):539-48
references.pmid: 20233903
references.citation: Mutat Res. 2009 Jul-Aug;682(1):1-6
references.pmid: 19401186
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):511-9
references.pmid: 15066913
references.citation: Scand J Public Health. 2007;35(4):432-41
references.pmid: 17786808
references.citation: Breast Cancer Res. 2005;7(5):R745-52
references.pmid: 16168120
references.citation: Chronobiol Int. 2010 Jul;27(5):1093-104
references.pmid: 20636218
references.citation: Arch Pharm (Weinheim). 2009 Mar;342(3):133-49
references.pmid: 19274700
references.citation: PLoS One. 2008 Jul 16;3(7):e2656
references.pmid: 18628976
references.citation: Cancer Res. 2010 Feb 15;70(4):1459-68
references.pmid: 20124474
references.citation: Int J Epidemiol. 1991 Dec;20(4):900-5
references.pmid: 1800428
references.citation: Chronobiol Int. 2010 Oct;27(9-10):1911-29
references.pmid: 20969531
references.citation: FASEB J. 1992 Feb 1;6(3):853-60
references.pmid: 1740235
references.citation: Cancer Res. 2007 Nov 1;67(21):10117-22
references.pmid: 17974952
references.citation: Lancet Oncol. 2007 Dec;8(12):1065-6
references.pmid: 19271347
references.citation: Clin Cancer Res. 2009 May 1;15(9):3163-71
references.pmid: 19383825
references.citation: J Epidemiol Community Health. 2010 Dec;64(12):1025-6
references.pmid: 20630981
references.citation: Am J Epidemiol. 1987 Apr;125(4):556-61
references.pmid: 3548332
references.citation: Clin Cancer Res. 2004 Aug 15;10(16):5349-54
references.pmid: 15328171
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4890-5
references.pmid: 20304803
references.citation: Neoplasma. 2010;57(5):465-72
references.pmid: 20568901